A randomized, phase 3, double-blind trial examining methotrexate and etanercept as monotherapy or in combinstion for treating psoriatic arthritis: A comparison of the composite measures used to evaluate disease activity

Схожі ресурси

• Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis
  за авторством: Coates, L, та інші
  Опубліковано: (2020)
• Design and rationale of the Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA)
  за авторством: Mease, P, та інші
  Опубліковано: (2018)
• Methotrexate in psoriasis and psoriatic arthritis
  за авторством: Coates, L, та інші
  Опубліковано: (2020)
• Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial
  за авторством: Helliwell, PS, та інші
  Опубліковано: (2022)
• Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: a randomised, placebo-controlled substudy of OPAL Balance
  за авторством: Nash, P, та інші
  Опубліковано: (2020)